The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study

Background: The incidence of TB among Inuit is the highest in Canada. A significantly shorter latent TB infection (LTBI) treatment with rifapentine and isoniazid once weekly for 12 weeks (3HP) is now available in limited settings in Canada. Methods: A prospective open-label 2-year observational pos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Circumpolar Health
Main Authors: Alvarez, G. G., Van Dyk, D., Mallick, R., Lesperance, S., Demaio, P., Finn, S., Potvin, S. Edmunds, Patterson, M., Pease, C., Amaratunga, K., Hui, C., Cameron, D.W., Mulpuru, S., Aaron, S.D., Momoli, F., Zwerling, A.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7241515/
https://ncbi.nlm.nih.gov/pubmed/32379538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/22423982.2020.1758501
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados